Genetic alterations detected in cell-free DNA are associated with enzalutamide and abiraterone resistance in castration-resistant prostate cancer

Samantha Torquato, Aparna Pallavajjala, Alexa Goldstein, Patricia Valda Toro, John L. Silberstein, Justin Lee, Mary Nakazawa, Ian Waters, David Chu, Daniel Shinn, Taylor Groginski, Robert M. Hughes, Brian W. Simons, Hamda Khan, Zhaoyong Feng, Michael A. Carducci, Channing J. Paller, Samuel R. Denmeade, Bruce Kressel, Mario A. EisenbergerEmmanuel S. Antonarakis, Bruce J. Trock, Ben H. Park, Paula J. Hurley

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Genetic alterations detected in cell-free DNA are associated with enzalutamide and abiraterone resistance in castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences